Trial Condition(s):
Acute Exacerbation Of Chronic Bronchitis, Community Acquired Pneumonia, Pelvic Inflammatory
Concentrations of moxifloxacin in gynecological tissues after single i.v. infusion of 400 mg in patients undergoing elective gynecological surgery
Bayer Identifier:
11134
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
Please see attached Study Results Summary below
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
43
Trial Dates
Phase
1
Could I receive a placebo?
No
Products
Avelox (Moxifloxacin hydrochloride, BAY12-8039)
Accepts Healthy Volunteers
N/A
Where to Participate
Loading...
Locations
| Locations | |
|---|---|
Locations Klinikum der Eberhard-Karls-Universität Tübingen Tübingen, Germany, 72076 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations CRS Clinical-Research-Services Kiel GmbH Kiel, Germany, 24105 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Klinikum der Eberhard-Karls-Universität Tübingen Tübingen, Germany, 72076 | Contact Us: E-mail: [email protected] Phone: Not Available |
For details, please refer to trial results
Additional Information
Copyright © Bayer
Powered by
